Past Events

THE 2020 ASTRO ANNUAL MEETING

-

The 2020 ASTRO Annual Meeting The 2020 ASTRO Annual Meeting has transitioned from a live meeting to an enhanced virtual educational experience. The meeting will include all of the programming you are accustomed to, only this year it will be in an interactive online format including a robust program of educational and scientific sessions, live SA-CME…

Continue reading

2020 October FCS Clinical Summit

-

The program will feature 7 distinct modules, each covering a specific tumor type to include breast cancer, chronic lymphocytic leukemia and lymphomas, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, lung cancer and multiple myeloma.

Continue reading
Lung Cancer and COVID-19 in the Outpatient Setting: What Clinicians Need to Know

Lung Cancer and COVID-19 in the Outpatient Setting: What Clinicians Need to Know [Oct 15]

-

  Course Type: Live CME/CE Webinar  Number of Credits: 1 Credit Type: CME/CE-certified, MOC-eligible Patients with underlying health conditions such as lung cancer are at greater risk for infection or complications from COVID-19. Because of this increased risk, it is important that these patients are carefully managed, with telemedicine replacing in-person visits where possible. However, monitoring patients via telemedicine…

Continue reading

Highlights of Rapid Integration Training Program: Focus on Inpatients

-

Thank you for your participation in the 2020 Rapid Integration FLASCO Half Day Reviews: What you need to know as a NEW Heme/Onc APP. The Focus on Inpatients was held on Saturday, October 10, 2020, from 8:00-11:00 am. The following was presented: 8:00-9:00 am How to Manage Newly Diagnosed Heme Malignancy Patients Steve Fein, MD…

Continue reading

NEW Immuno-Oncology Proactive Patient Management Webinar

-

Join us for a NEW educational series: Immuno-Oncology Proactive Patient Management a Three-Part Series This APP focused series is designed to increase foundational knowledge of I-O therapy, enhance ability to educate patients, and better identify/understand the management of IMARs. This event progresses to completion and is best viewed in sequence, please participate in the suggested…

Continue reading
Lung Cancer and COVID-19 in the Outpatient Setting: What Clinicians Need to Know

Lung Cancer and COVID-19 in the Outpatient Setting: What Clinicians Need to Know [Sept 29]

-

  Course Type: Live CME/CE Webinar  Number of Credits: 1 Credit Type: CME/CE-certified, MOC-eligible Patients with underlying health conditions such as lung cancer are at greater risk for infection or complications from COVID-19. Because of this increased risk, it is important that these patients are carefully managed, with telemedicine replacing in-person visits where possible. However, monitoring patients via telemedicine…

Continue reading
Sanofi Genzyme

Unusual Suspects: Lysosomal Storage Diseases in the Hematology/Oncology Patient Population

-

  Unusual Suspects: Lysosomal Storage Diseases in the  Hematology/Oncology Patient Population   Thursday, September 17, 2020 6:00 PM – 7:00 PM *Free for FLASCO Members Join us for a session on Gaucher Disease Type 1. The program will feature Neal J. Weinreb, M.D., FACP, an expert speaker, providing an education on what’s behind your patient’s…

Continue reading
Sanofi Genzyme

Unusual Suspects: Lysosomal Storage Diseases in the Hematology/Oncology Patient Population

-

  Unusual Suspects: Lysosomal Storage Diseases in the  Hematology/Oncology Patient Population   Wednesday, September 16, 2020 12:15 PM – 1:15 PM *Free for FLASCO Members Neal J. Weinreb, M.D., FACP will present an educational event on what’s behind your patient’s hematological abnormalities. Dr. Weinreab practiced Hematology and Medical Oncology in South Florida for 40 years. He…

Continue reading
Lung Cancer and COVID-19 in the Outpatient Setting: What Clinicians Need to Know

Lung Cancer and COVID-19 in the Outpatient Setting: What Clinicians Need to Know [Sept 15]

-

  Course Type: Live CME/CE Webinar  Number of Credits: 1 Credit Type: CME/CE-certified, MOC-eligible Patients with underlying health conditions such as lung cancer are at greater risk for infection or complications from COVID-19. Because of this increased risk, it is important that these patients are carefully managed, with telemedicine replacing in-person visits where possible. However, monitoring patients via telemedicine…

Continue reading

© 2020 FLASCO | Premium Website Design by The HDG

FLASCO